Kangfeng Biotechnology (Shanghai) Co.
Latest round
- Series B
Last raised
- Feb 2021
Total raised
- $1.1B
Investors
- 9
About Kangfeng Biotechnology (Shanghai) Co.
, Ltd. operates as a cryo-medical technology platform that focuses on vascular intervention and trans-natural lumen field. The core research team has more than ten years of experience in R&D and practical engineering application of medical device. In December 2022, the company was listed on the Hongkong stock exchange and its stock code is 06922. In 2022, its products - bladder tumor cryoablation system and endoscopic anastomosis clips obtain registration certificate. The company provides cryotherapy solutions. Its products are divided into cryotherapy system and non-cryotherapy products. Cryotherapy system includes atrial fibrillation, hypertension and bladder cancer, etc. Non-cryotherapy products includes new endoscopic anastomotic clamp and anti-gastroesophageal reflux system.
Who invested in Kangfeng Biotechnology (Shanghai) Co.
9 investors across 3 rounds
See all investors in Kangfeng Biotechnology (Shanghai) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kangfeng Biotechnology (Shanghai) Co.
Who invested in Kangfeng Biotechnology (Shanghai) Co.?
Kangfeng Biotechnology (Shanghai) Co. has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kangfeng Biotechnology (Shanghai) Co. raised?
Kangfeng Biotechnology (Shanghai) Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Kangfeng Biotechnology (Shanghai) Co. last raise money?
Kangfeng Biotechnology (Shanghai) Co.'s most recent round on record is a Series B, in Feb 2021.
What does Kangfeng Biotechnology (Shanghai) Co. do?
Kangfeng Biotechnology (Shanghai) Co. is a medical devices & equipment company.
Where is Kangfeng Biotechnology (Shanghai) Co. headquartered?
Kangfeng Biotechnology (Shanghai) Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Kangfeng Biotechnology (Shanghai) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Kangfeng Biotechnology (Shanghai) Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Kangfeng Biotechnology (Shanghai) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.